Pancreas transplant alone determines early improvement of cardiovascular risk factors and cardiac function in type 1 diabetic patients

Transplantation

Volumn 76, Issue 6, 2003, Pages 974-976

  Coppelli, Alberto ^a   Giannarelli, Rosa ^a   Mariotti, Rita ^a   Rondinini, Lorenzo ^a   Fossati, Nicoletta ^a   Vistoli, Fabio ^a   Aragona, Michele ^a   Rizzo, Gaetano ^a   Boggi, Ugo ^a   Mosca, Franco ^a   Del Prato, Stefano ^a   Marchetti, Piero ^a  

^a CISANELLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE METABOLISM; GRAFT REJECTION; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID METABOLISM; MALE; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; CREATININE; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FUNCTION TESTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 0141433196     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000084202.18999.1D     Document Type: Article

References (10)

1. American Diabetes Association. Pancreas transplantation for patients with type 1 diabetes. Diabetes Care 2002; 25: S111.
2. Sutherland DE, Gruessner RW, Dunn DL, et al. Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg 2001; 233(4): 463-501.
3. Henley SH, Akhter J, Stratta RJ, et al. Lipids increase after solitary pancreas transplantation. Diabetes Care 1999; 22: 320-327.
4. Monzani F, Di Bello V, Caraccio N, et al. Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: A double blind, placebo-controlled study. J Clin Endocrinol Metab 2001; 86: 1110-1115.
5. Fiorina P, La Rocca E, Venturini M, et al. Effects of kidney-pancreas transplantation on atherosclerotic risk factors and endothelial function in patients with uremia and type 1 diabetes. Diabetes 2001; 50: 496-501.
6. Carpentier A, Patterson BW, Uffelman KD, et al. The effect of systemic versus portal insulin delivery in pancreas transplantation on insulin action and VLDL metabolism. Diabetes 2001; 50: 1402-1413.
7. Bruttomesso D, Iori E, Kiwanuka E, et al. Insulin infusion normalizes fasting and post-prandial albumin and fibrinogen synthesis in type 1 diabetes mellitus. Diabet Med 2001; 18: 915-920.
8. Mellinghoff AC, Reininger AJ, Land W, et al. Cardiovascular risk profile after simultaneous pancreas and kidney transplantation. Exp Clin Endocrinol Diabetes 1998; 106: 460-464.
9. Forst T, De La Tour DD, Kunt T, et al. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+, K+-AT-Pase activity in diabetes mellitus type I. Clin Sci (Lond) 2000; 98: 283-290.
10. La Rocca E, Fiorina P, di Carlo V, et al. Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation. Kidney Int 2001; 60: 1964-1971.